跳至主要内容
临床试验/ACTRN12616000534482
ACTRN12616000534482进行中(未招募)未知

Evaluation of the Role Of Magnetic Resonance Imaging (MRI) in Mucosal Primary Head and Neck Cancer

Dr Myo Min0 个研究点目标入组 34 人开始时间: 2016年4月26日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 18 years or older
  • - Have the ability to give informed consent
  • - Histologically-proven invasive primary squamous cell carcinoma of mucosal primary head and neck region or patients with tumours strongly suspicious for mucosal primary head and neck cancer due to clinical features AND fine needle aspiration (FNA) cytology assessment
  • - Primary mucosal head and neck cancer (greater than or equal to T2 and/or greater than or equal to N1) AND no evidence of metastatic disease on staging PET/CT or CT (chest +/- abdomen +/- pelvis)
  • - Patient undergoing curative intent primary radiotherapy +/- chemotherapy

排除标准

  • - Contraindication to MRI studies including significant claustrophobia, pacemaker/implantable defibrillator, implanted metals eg. Intraocular clips, and/or known allergic reaction to Gadolinium (Gd)-DTPA
  • - Previous radiotherapy and/or surgery in the head and neck region
  • - Other malignancy (history of malignancy within 5 years)
  • - Pregnant

研究者

发起方
Dr Myo Min

相似试验